Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCNB1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CABP7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | AMH | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | IGSF9B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SYT5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | INSIG2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | USP30 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | RP11-295P9.13 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TDP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | PRKAR2A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |